Linder S, Falkmer U, Hagmar T, Blåsjö M, Sundelin P, von Rosen A
Department of Surgery, Karolinska Hospital, Stockholm, Sweden.
Pancreas. 1994 Nov;9(6):764-72. doi: 10.1097/00006676-199411000-00016.
The nuclear DNA content was assessed by image cytometry on cytologic specimens obtained with fine-needle aspiration biopsy in 96 patients with pancreatic duct carcinoma. Twenty-two of these patients had pancreaticoduodenal resection. According to DNA analysis there were 27 (28%) diploid, 17 (18%) tetraploid, and 52 (54%) aneuploid tumors. The corresponding patient median survival times were 8, 5, and 4 months, respectively. Resectable tumors were more often DNA diploid (10 of 22) than nonresectable tumors (17 of 74) (p < 0.05). A Cox multivariate regression analysis demonstrated that surgical resection (p < 0.001) and diploid DNA pattern (p < 0.05) were factors associated with longer patient survival time. Although the difference in survival time was small, the data indicate that DNA diploid tumors represent a less aggressive subset of pancreatic carcinoma.
通过图像细胞术对96例胰管癌患者细针穿刺活检获得的细胞学标本进行核DNA含量评估。其中22例患者接受了胰十二指肠切除术。根据DNA分析,有27例(28%)二倍体肿瘤、17例(18%)四倍体肿瘤和52例(54%)非整倍体肿瘤。相应患者的中位生存时间分别为8个月、5个月和4个月。可切除肿瘤中DNA二倍体的比例(22例中的10例)高于不可切除肿瘤(74例中的17例)(p<0.05)。Cox多因素回归分析表明,手术切除(p<0.001)和二倍体DNA模式(p<0.05)是与患者较长生存时间相关的因素。尽管生存时间差异较小,但数据表明DNA二倍体肿瘤是胰腺癌中侵袭性较小的一个亚组。